HOW TO TREAT UNFIT AND FRAIL PATIENTS von Cook, Gordon

Volltext

Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study von Bahlis, Nizar J., Dimopoulos, Meletios A., White, Darrell J., Benboubker, Lotfi, Cook, Gordon, Leiba, Merav, Ho, P. Joy, Kim, Kihyun, Takezako, Naoki, Moreau, Philippe, Kaufman, Jonathan L., Krevvata, Maria, Chiu, Christopher, Qin, Xiang, Okonkwo, Linda, Trivedi, Sonali, Ukropec, Jon, Qi, Ming, San-Miguel, Jesus

Volltext

Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE von San-Miguel, Jesus, Avet-Loiseau, Hervé, Paiva, Bruno, Kumar, Shaji, Dimopoulos, Meletios A., Facon, Thierry, Mateos, María-Victoria, Touzeau, Cyrille, Jakubowiak, Andrzej, Usmani, Saad Z., Cook, Gordon, Cavo, Michele, Quach, Hang, Ukropec, Jon, Ramaswami, Priya, Pei, Huiling, Qi, Mia, Sun, Steven, Wang, Jianping, Krevvata, Maria, DeAngelis, Nikki, Heuck, Christoph, Van Rampelbergh, Rian, Kudva, Anupa, Kobos, Rachel, Qi, Ming, Bahlis, Nizar J.

Volltext

LIQUID SCINTILLATION COUNTING (LSC)—PAST, PRESENT, AND FUTURE von Hogg, Alan G, Cook, Gordon T

Volltext

Land use and mobility during the Neolithic in Wales explored using isotope analysis of tooth enamel von Neil, Samantha, Montgomery, Janet, Evans, Jane, Cook, Gordon T., Scarre, Chris

Volltext

Using Carbon Isotopes to Fight the Rise in Fraudulent Whisky von Cook, Gordon T, Dunbar, Elaine, Tripney, Brian G, Fabel, Derek

Volltext

Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients von Weinhold, Niels, Salwender, Hans J, Cairns, David A, Raab, Marc S, Waldron, George, Blau, Igor W, Bertsch, Uta, Hielscher, Thomas, Morgan, Gareth J, Jauch, Anna, Davies, Faith E, Hänel, Mathias, Cook, Gordon, Scheid, Christoph, Houlston, Richard, Goldschmidt, Hartmut, Jackson, Graham, Kaiser, Martin F

Volltext

Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study von RAWSTRON, Andy C, CHILD, J. Anthony, ROSS, Fiona M, COOK, Gordon, JACKSON, Graham H, MORGAN, Gareth J, OWEN, Roger G, DE TUTE, Ruth M, DAVIES, Faith E, GREGORY, Walter M, BELL, Sue E, SZUBERT, Alexander J, NAVARRO-COY, Nuria, DRAYSON, Mark T, FEYLER, Sylvia

Volltext

Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction von Rawstron, Andy C., Gregory, Walter M., de Tute, Ruth M., Davies, Faith E., Bell, Sue E., Drayson, Mark T., Cook, Gordon, Jackson, Graham H., Morgan, Gareth J., Child, J. Anthony, Owen, Roger G.

Volltext

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial von Morgan, Gareth J, Dr, Prof, Davies, Faith E, MD, Gregory, Walter M, Prof, Cocks, Kim, MSc, Bell, Sue E, DPhil, Szubert, Alex J, MSc, Navarro-Coy, Nuria, MPhil, Drayson, Mark T, MD, Owen, Roger G, MD, Feyler, Sylvia, MD, Ashcroft, A John, MD, Ross, Fiona, DPhil, Byrne, Jennifer, MD, Roddie, Huw, MD, Rudin, Claudius, MD, Cook, Gordon, MD, Jackson, Graham H, Prof, Child, J Anthony, Prof

Volltext

Humics—Their History in the Radiocarbon Intercomparison Studies von Naysmith, Philip, Scott, E Marian, Dunbar, Elaine, Cook, Gordon T

Volltext

The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis von Morgan, Gareth J., Gregory, Walter M., Davies, Faith E., Bell, Sue E., Szubert, Alexander J., Brown, Julia M., Coy, Nuria N., Cook, Gordon, Russell, Nigel H., Rudin, Claudius, Roddie, Huw, Drayson, Mark T., Owen, Roger G., Ross, Fiona M., Jackson, Graham H., Child, J. Anthony

Volltext

Multiple Myeloma: EHA‐ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow‐up von Dimopoulos, Meletios A., Moreau, Philippe, Terpos, Evangelos, Mateos, María‐Victoria, Zweegman, Sonja, Cook, Gordon, Delforge, Michel, Hájek, Roman, Schjesvold, Fredrik, Cavo, Michele, Goldschmidt, Hartmut, Facon, Thierry, Einsele, Hermann, Boccadoro, Mario, San‐Miguel, Jesús, Sonneveld, Pieter, Mey, Ulrich

Volltext

Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly di... von Jones, John R, Weinhold, Niels, Ashby, Cody, Walker, Brian A, Wardell, Chris, Pawlyn, Charlotte, Rasche, Leo, Melchor, Lorenzo, Cairns, David A, Gregory, Walter M, Johnson, David, Begum, Dil B, Ellis, Sidra, Sherborne, Amy L, Cook, Gordon, Kaiser, Martin F, Drayson, Mark T, Owen, Roger G, Jackson, Graham H, Davies, Faith E, Greaves, Mel, Morgan, Gareth J

Volltext

Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry von Irving, Adam, Petrie, Dennis, Harris, Anthony, Fanning, Laura, Wood, Erica M, Moore, Elizabeth, Wellard, Cameron, Waters, Neil, Huynh, Kim, Augustson, Bradley, Cook, Gordon, Gay, Francesca, McCaughan, Georgia, Mollee, Peter, Spencer, Andrew, McQuilten, Zoe K

Volltext

Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life von Terpos, Evangelos, Mikhael, Joseph, Hajek, Roman, Chari, Ajai, Zweegman, Sonja, Lee, Hans C., Mateos, María-Victoria, Larocca, Alessandra, Ramasamy, Karthik, Kaiser, Martin, Cook, Gordon, Weisel, Katja C., Costello, Caitlin L., Elliott, Jennifer, Palumbo, Antonio, Usmani, Saad Z.

Volltext

Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and... von Mateos, Maria-Victoria, Spencer, Andrew, Nooka, Ajay K, Pour, Ludek, Weisel, Katja, Cavo, Michele, Laubach, Jacob P, Cook, Gordon, Iida, Shinsuke, Benboubker, Lotfi, Usmani, Saad Z, Yoon, Sung-Soo, Bahlis, Nizar J, Chiu, Christopher, Ukropec, Jon, Schecter, Jordan M, Qin, Xiang, O'Rourke, Lisa, Dimopoulos, Meletios A

Volltext

Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma von Rule, Simon, Cook, Gordon, Russell, Nigel H., Hunter, Ann, Robinson, Stephen, Morley, Nick, Sureda, Anna, Patrick, Pip, Clifton‐Hadley, Laura, Adedayo, Toyin, Kirkwood, Amy, Peggs, Karl S.

Volltext

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation von Marks, David I., Pagliuca, Antonio, Kibbler, Christopher C., Glasmacher, Axel, Heussel, Claus‐Peter, Kantecki, Michal, Miller, Paul J.S., Ribaud, Patricia, Schlamm, Haran T., Solano, Carlos, Cook, Gordon

Volltext

High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignanc... von Cook, Gordon, Iacobelli, Simona, van Biezen, Anja, Ziagkos, Dimitris, LeBlond, Veronique, Abraham, Julie, McQuaker, Grant, Schoenland, Stefan, Rambaldi, Alessandro, Halaburda, Kazimierz, Rovira, Maria, Sica, Simona, Byrne, Jenny, Sanz, Ramon Garcia, Nagler, Arnon, van de Donk, Niels W C J, Sinisalo, Marjatta, Cook, Mark, Kröger, Nicolaus, De Witte, Theo, Morris, Curly, Garderet, Laurant

Volltext